Research versus development boundary for new product and process engineering

Manufacturers with active engineering functions face constant pressure to capitalize costs to protect reported profit, but premature or retroactive capitalization overstates intangible assets and understates period expense, while excessive conservatism (expensing genuine development) understates assets and distorts R&D intensity metrics used by investors and, in some jurisdictions, R&D tax incentive claims; getting the boundary right also affects comparability of margins across a manufacturer's product-development cycle.

Has each engineering activity been classified as research (exploring alternatives, no committed direction) versus development (designing a specific, chosen product/process for production)? Can management demonstrate, with evidence, that technical feasibility, intent, resources and probable future benefit are all met simultaneously before capitalization begins? Is a reliable cost-tracking mechanism in place from the criteria-met date, so that already-expensed research costs are not retroactively capitalized?

1. Classify each internal engineering activity as research (seeking new knowledge, evaluating and screening alternative technologies or designs, general exploratory investigation with no committed direction) or development (designing, constructing and testing a chosen, specific product or process ahead of commercial production).
2. Expense all research-phase costs as incurred; do not delay expensing while feasibility is still being assessed.
3. Move to potential capitalization only once management can demonstrate, with evidence, that all of the required conditions are met together: technical feasibility of completing the asset, intention to complete and use or sell it, ability to use or sell it, how it will generate probable future economic benefits (e.g., existence of a market or internal use case), availability of adequate technical, financial and other resources to complete it, and the ability to measure the attributable expenditure reliably.
4. Begin capitalization only from the date all conditions are first demonstrably met - never capitalize retroactively to project inception once feasibility is confirmed later.
5. Establish a reliable cost-tracking mechanism from that date forward, capturing only expenditure directly attributable to creating, producing and preparing the asset for its intended use.
6. Continue to monitor the project for indicators of abandonment or failure to meet the conditions; stop capitalizing and expense further costs (and consider impairment of costs already capitalized) if the project is no longer expected to proceed to commercial use.

Measurement basis: capitalized development cost is measured at directly attributable expenditure incurred from the date all capitalization conditions are first met, including materials, direct labor, and a reasonable allocation of overhead directly attributable to preparing the asset for its intended use. Included: costs incurred from the criteria-met date forward only. Excluded: research-phase costs, general and administrative overhead not directly attributable, training costs, and identified inefficiencies/losses incurred during development, all of which are expensed. Subsequent measurement: capitalized development costs are not amortized while the resulting asset is not yet available for use; amortization begins once the asset (new product or process) is ready for its intended use, over its useful life. Remeasurement/impairment trigger: reassess for impairment if indicators arise (e.g., project delay, technology superseded, loss of market interest), and derecognize/impair unamortized costs if the project is abandoned.

Disclose: (1) the aggregate research and development expense recognized in profit or loss for the period; (2) the accounting policy describing the point at which development costs begin to be capitalized and the conditions assessed; (3) the carrying amount of capitalized development costs (intangible assets under construction/completed), and the amortization method and useful life once available for use; (4) any impairment losses recognized on capitalized development costs, including for abandoned projects; (5) significant judgments applied in determining the research/development boundary, if material to understanding the financial statements.

• Capitalizing costs retroactively from project inception once feasibility is established later in the project'
• s life, rather than only from the date all conditions are first met
• capitalizing pure research or exploratory engineering costs (e.g., screening multiple unproven alternatives) as if they were already development costs
• continuing to capitalize costs after a project is effectively abandoned or redirected, without testing the accumulated balance for impairment
• capitalizing costs without a reliable, contemporaneous cost-tracking system, relying instead on rough after-the-fact allocations that cannot be substantiated
• treating routine or minor product modifications and troubleshooting as development when they do not represent a substantively new product or process.